Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Kawazoe A, Fukuoka S, Nakamura Y, Kuboki Y, Mikamoto Y, Shima H. et al.
An open-label phase II study of lenvatinib plus pembrolizumab in patients with advanced gastric cancer (EPOC1706).

J Clin Oncol 2020;
38 Suppl 4: 374-4

Bibliographische Angaben herunterladen

Aufrufen in: